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The Osteochondral Interface as a Gradient Tissue: From
Development to the Fabrication of Gradient Scaffolds for
Regenerative Medicine
Andrea Di Luca*1, Clemens Van Blitterswijk1,2, and Lorenzo Moroni1,2
The osteochondral (OC) interface is not only the interface between two
tissues, but also the evolution of hard and stiff bone tissue to the softer and
viscoelastic articular cartilage covering the joint surface. To generate a smooth
transition between two tissues with such differences in many of their
characteristics, several gradients are recognizable when moving from the
bone side to the joint surface. It is, therefore, necessary to implement such
gradients in the design of scaffolds to regenerate the OC interface, so to
mimic the anatomical, biological, and physicochemical properties of bone and
cartilage as closely as possible. In the past years, several scaffolds were
developed for OC regeneration: biphasic, triphasic, and multilayered scaffolds
were used to mimic the compartmental nature of this tissue. The structure of
these scaffolds presented gradients in mechanical, physicochemical, or
biological properties. The use of gradient scaffolds with already differentiated
or progenitor cells has been recently proposed. Some of these approaches
have also been translated in clinical trials, yet without the expected
satisfactory results, thus suggesting that further efforts in the development of
constructs, which can lead to a functional regeneration of the OC interface by
presenting gradients more closely resembling its native environment, will be
needed in the near future. The aim of this review is to analyze the gradients
present in the OC interface from the early stage of embryonic life up to the
adult organism, and give an overview of the studies, which involved gradient
scaffolds for its regeneration.
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Introduction
Osteoarthritis (OA) nowadays represents worldwide, a
common degenerative disease in old people with a high
socio-economic impact. It has been estimated that 40% of
the population over 65 years presents symptomatic OA in
large joints, consequently affecting the quality of life of
elderly populations (Dunlop et al., 2001; Mannoni et al.,
2003; Dawson et al., 2004). The increase of life expectancy
will eventually increase the percentage of population pre-
senting OA. Clinically, current therapies to regenerate
osteochondral (OC) tissues are not yet completely success-
ful. All the available treatments such as reparative surgery,
allografts, autografts, and the implantation/transplantation
of autologous chondrocytes, besides limitations like the
formation of fibrocartilage and lack of donor supply, inflict
further tissue damage before any therapeutic effect can be
achieved (Schaefer! et al., 2000; Martin et al., 2007). Due
to the fore-mentioned reasons, major efforts in regenera-
tive medicine have been placed in the past few years to
present new solutions that hold the potential to improve
the outcome of current therapies. Scaffold-based regenera-
tive medicine strategies, in particular, have found a lot of
applications in the past decades in skeletal tissue engi-
neering, due to their ability to support cells and tissue
growth in 3D and to mimic to some extent the extracellu-
lar matrix (ECM) architectural properties and composition.
The OC tissue is located at the end of long bones and
allows the transition from bone to cartilage. Since these
two anatomical structures present significantly different
characteristics at the macroscales, microscales, and nano-
scales in terms of structural, mechanical, physicochemical,
and biological properties, an interfacial tissue that shows a
gradual variation of these features at different scales is
necessary. Due to the fine interplay between the bone and
the cartilage side, the two compartments cannot be sepa-
rated, since they are tightly interconnected not only under
physiological conditions, but also during the progression
of OA. When thinking about the regeneration of the OC tis-
sue, designing scaffold-based regenerative strategies that
can take into consideration such graded variations of the
native tissue properties seems, therefore, a promising
route. In the past few years, a number of scaffolds pre-
senting either a biphasic or triphasic (Schek et al., 2004;
Grayson et al., 2010; Aydin, 2011, Kon et al., 2011; Leving-
stone et al., 2014; Shimomura et al., 2014) structure were
proposed for the regeneration of the OC tissue in vitro and
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in vivo. Constructs presenting a discrete or continuous gra-
dients in geometry (Woodfield et al., 2004), stiffness (Lev-
ingstone et al., 2014), biochemical composition (Benders
et al., 2013; Levingstone et al., 2014) at the macroscale
and microscale, as well as gradients in growth factor con-
centrations (Singh et al., 2008; Oh et al., 2011; Zhang
et al., 2012), can be found in literature. The aim of this
review is to dissect the gradient nature of the OC tissue,
such as its changes in ECM molecular composition and ori-
entation, the resulting variation in physicochemical and
mechanical properties, as well as in the cellularity, nutri-
ent availability, and growth factors involved in its develop-
ment, This knowledge is then linked to the strategies
applied so far in regenerative medicine for OC tissue
regeneration.
OC Tissue Development
From a developmental point of view, bone and cartilage of
appendicular bones arise from the lateral plate mesoderm.
The first step in their development is the condensation of
OC progenitor cells into aggregates under the effect of
transforming growth factor (TGF-b), which promotes the
expression of molecules involved in the condensation pro-
cess such as N-cadherin, neural cella adhesion molecule (N-
CAM), fibronectin, and Tenascin-C (Chimal-Monroy and Diaz
de Leon, 1999; Kronenberg, 2003). The condensation deter-
mines the formation of a central part of cells, which con-
tinue to proliferate and express the transcription factor sex
determining region Y-box 9 (sox-9), and a population of
cells located in the periphery of the aggregates known as
the perichondrium (Nakashima and de Crombrugghe,
2003). Sox-9 is expressed in all the chondrocytes with the
exception of hypertrophic chondrocytes (de Crombrugghe
et al., 2001). The perichondrium functions as a reservoir of
chondrocytes during bone development, which will pro-
gress until bone formation. Under the influence of a growth
factor cocktail, including amongst others insulin growth
factor-1, fibroblast growth factor-2, and bone morphoge-
netic proteins (BMPs) -2, -4, -7, and -14 (Kronenberg, 2003;
Pogue and Lyons, 2006; Wang et al., 2011), the cells within
the aggregates proceed to chondroblasts and begin to pro-
duce aggrecan and collagen type II, IX, and XI. Chondro-
blasts organize into a structure called growth plate, from
which bone will be generated. The central part of the
growth plate is called the primary ossification center and
constitutes the first cartilage portion replaced by bone. The
growth plate is responsible for the growth in length of
appendicular bones during life. Within the growth plate dif-
ferent zones can be identified, each one characterized by a
pool of chondrocytes displaying differences in size, prolifer-
ation rate, and ECM deposition. At the distal end of long
bones, chondrocytes appear small and rounded. Chondro-
cytes are located in the so called resting zone, which has
the function of providing further cells that will continue in
the maturation process. Once stimulated, resting zone chon-
drocytes interact with the surrounding ECM, assume a flat
phenotype, and begin the formation of the columnar zone.
Near the top of the columnar zone, cells display the highest
proliferation rate (Smits et al., 2004). Cell proliferation is
maintained by the action of parathyroid hormone-related
peptide (PTHrP), which is produced by periarticular chon-
drocytes and negatively regulates terminal cell differentia-
tion (Kobayashi et al., 2002; Kronenberg, 2003). As we
move from the periarticular zone into the resting and
columnar zones, chondrocytes move away from the PTHrP
source, arrest their proliferation, and undergo prehypertro-
phic differentiation at the bottom of the columnar zone.
Prehypertrophic chondrocytes produces Indian hedgehog
(IHH), which stimulates on one side PTHrP synthesis by
periarticular chondrocytes, and on the other side cell termi-
nal differentiation and hypertrophic zone formation. Their
volume increases by 20-fold (Goldring et al., 2006) and
their ECM synthesis switches from mainly collagen type II
to collagen type X formation. The furthest chondrocyte
developmental stage is the late hypertrophic chondrocyte,
which expresses some preosteoblast markers such as
matrix metalloproteinase (MMP-13), known to promote vas-
cular invasion and the consequent progressive replacement
of cartilage by bone. Late hypertrophic chondrocytes repre-
sent the terminal stage of differentiation in the chondro-
genic cell lineage (Pacifici et al., 1990). The final fate of
hypertrophic chondrocytes is apoptosis, but cells which
escape death become osteoblasts (Bianco et al., 1998). The
cells of the perichondrium flanking the hypertrophic zone
become osteoblasts and form the periosteum, under the
effect of Runt-related transcription factor 2 (Runx-2). The
hypertrophic chondrocyte begins to express Runx-2, an
early marker for osteogenesis and continue to be expressed
in osteoblasts. Blood vessel and osteoblasts from the newly
formed bone invade the hypertrophic region and replace
cartilage with bone and bone marrow (Kronenberg, 2003).
Many of the events in chondrogenesis, from early dif-
ferentiation of hMSCs in prechondrocytes to the evolution
toward the hypertrophic stage, are governed by the Wnt
signaling pathway. This pathway can follow two distinct
routes named Wnt “canonical” and “noncanonical” path-
ways. In the b-catenin or canonical pathway, Wnt binds its
receptor Frizzled, which activate glycogen synthase kinase-
3b (GSK-3b) that determines the phosphorylation of b-
catenin. In its phosphorylated form, b-catenin is stable and
accumulates in the cytoplasm. Subsequently, b-catenin
translocates to the nucleus and interacts with the gene
expression regulatory apparatus (Yates et al., 2005). The
noncanonical pathway is b-catenin independent and based
on intracellular calcium levels. The binding of Wnt with
Frizzled stimulates the release of intracellular Ca11 and
the activation of protein kinase C and Ca21-calmodulin-
dependent protein kinase II, which are involved in ventral
patterning and regulation of cell adhesion, migration, and
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tissue separation (K€uhl et al., 2000; Komiya and Habas,
2008). In contrast to what happens in the growth plate,
articular cartilage is highly resistant to the hypertrophic
differentiation (Leijten et al., 2012). The control of chon-
drocyte differentiation relies on the expression of antago-
nists of the Wnt signaling pathway such as Gremlin 1,
Frizzled-Related Protein, and Dickkopf-1 (Dkk-1; Kawano
and Kypta, 2003). Beside the Wnt family, another pool of
proteins actively involved in chondrogenic and osteogenic
development is represented by the transforming growth
factor b (TGF-b) superfamily. Within the TGF-b superfam-
ily, BMPs and TGF-bs are the most important growth fac-
tors known to regulate osteogenic and chondrogenic cell
differentiation (Chen et al., 2012). There are three TGF-b
isoforms, namely TGF-b 1, 2, and 3. TGF-b1 and TGF-b3
are related to chondrogenesis. The effectors of the canoni-
cal pathways are the small mothers against decapentaple-
gic proteins (Smads), a pool of cytoplasmic proteins able
to form complexes which translocate in the nucleus and
act as transcription factors (Heldin et al., 1997). Smad-1, -
2, -3, -5, and -8 are effectors of the TGF-b and BMP path-
ways. Smad-4 acts as cofactor, forming the complex, which
translocate in the nucleus, whereas Smad-6 and -7 have
an inhibitory activity (Itoh et al., 2001). In TGF-b pathway,
one TGF-b isoform binds a type II dimeric receptor, which
recruits a dimeric type I receptor generating a heterotetra-
meric complex. This complex presents a kinase intracellu-
lar domain, type II receptor phosphorylates type I
receptor (Heldin et al., 1997), which phosphorylates
Smad-2 or Smad-3. This event causes the formation of the
Smad2/3-Smad4 complex, its translocation in the nucleus
and the action as transcription factor, increasing the Sox9-
dependent transcriptional activity and the transcription of
collagen type IIa1 (Furumatsu et al., 2005; Lin et al.,
2005). BMP family also consists of several isoforms. BMP-
2, -6, and -7 are known to promote osteogenic differentia-
tion whereas BMP-3 act as an inhibitor. The BMP pathway
presents the same event sequence. The BMP binds a heter-
ocomplex composed of a type I and a type II receptor.
Binding generates the recruitment of other, in order to
form the heterotetrameric complex. Type II receptor phos-
phorylates type I receptor, which phosphorylates Smad-1, -
5 or -8 (Mundy, 2006). This event causes the formation of
the Smad-1/5/8-Smad-4 complex, which translocates into
the nucleus determining the transcription of Runx2, colla-
gen typeIa2, alkaline phosphatase, and osteocalcin (Mundy,
2006).
The Components of OC Tissue
The OC tissue is composed by two main compartments,
subchondral bone and articular cartilage (Kwan et al.,
2009). Within these compartments, a further division in
areas can be performed. Beside the subchondral bone
plate, the calcified cartilage is often considered part of it;
the line defining the passage to the articular cartilage is
the so-called tide mark. Articular cartilage can be further
divide into three regions: (i) the radial zone, standing on
top of mineralized cartilage; (ii) the transition zone, cen-
tral in the cartilage tissue; (iii) and the superficial zone,
interfacing with the synovial fluid and the joint space. The
OC tissue has an height of 3 mm in adults, of which
about 90% consists of articular cartilage, 5% calcified car-
tilage, and 5% the subchondral bone plate (Hunziker et al.,
2002). A schematic representation and histological section
of the components of the OC tissue are shown in Figure 1.
SUBCONDRAL BONE AND CALCIFIED CARTILAGE
Long bones are divided into diaphysis, being the central
part of the bone, and the epiphysis, localized in proximity
of the joints. The structure of bone in the two compart-
ments differs by the radial variation of bone compactness.
In the diaphysis, a zone of more compact bone, called cort-
ical bone, can be identified in the external part. Cortical
bone presents a porosity ranging from 5 to 30% and a
bone volume fraction ranging from 85 to 90%. Moving
towards the center, a more porous structure, called cancel-
lous or trabecular bone, is encountered. The porosity of
trabecular bone ranges from 30 to 90% and its bone vol-
ume fraction from 5 to 60%. Bone volume fraction
decreases when moving toward the bone marrow channel,
in which the space between the trabecula is wider and
filled with the bone marrow. The subchondral bone in the
epiphysis presents similar characteristics of the trabecular
bone with bone volume fraction ranging from 6 to 36%, a
trabecular thickness of 100–190 mm, a trabecular concen-
tration ranging from 0.61 to 2.06 trabecules/mm, and the
space between them ranging from 320 to 1670 mm (Bobi-
nac et al., 2003). At the epiphysis, the compact bone is
reduced to a thin layer. The subchondral bone serves to
keep the integrity of the overlying articular cartilage
(Sharma et al., 2013). At the molecular and cellular level,
bone and cartilage differ significantly from each other.
Bone ECM is mainly based on collagen type I collagen
fibrils with mineral deposits of calcium and phosphate,
called hydroxyapatite (HA). Beside collagen, other struc-
tural proteins are present. Among them the most impor-
tant are osteopontin, thrombospondin, and bone
sialoprotein for cell and HA attachment, and osteocalcin
and osteonectin for the binding of HA and calcium respec-
tively (Heinegard and Oldberg, 1989). Being a vascularized
tissue and due to the presence of the bone marrow, the
cell composition of bone is very heterogeneous. Within the
bone marrow, a small fraction (0.002%) is represented by
mesenchymal stromal/stem cells (hMSCs), which are the
precursor, among others, of osteoblasts, osteoclasts, and
chondrocytes. Osteoblasts are the cells responsible for HA
synthesis, and deposition. Osteoclasts have an opposite
activity, being responsible for bone resorption. Beside their
structural function, bones represent the reservoir of
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calcium for the human body. The activity of osteoblasts
and osteoclasts is fine-tuned by hormones depending on
the request of calcium from the body, which results in a
process of bone synthesis and remodeling through the
whole life of an individual (Harada and Rodan, 2003). The
interplay between osteoblasts and osteoclasts is further
controlled by osteocytes, the most abundant cell in bone
tissue (Knothe Tate et al., 2004). Besides being actively
involved in maintaining the bony matrix, the osteocytes
are also mechanotransductors. Their immersion in the
bone matrix and connection with adjacent osteocytes in
the canaliculi allows exogenous and endogenous signals to
be transmitted via mechanical, electrical, and chemical
mechanisms (Knothe Tate et al., 2004). Another cell type
present in this tissue is the endothelial cells forming the
blood vessels, which run through the bones. Moving from
the epiphysis toward the joint, the first portion of the car-
tilage encountered is the calcified zone. It is considered
together with the subchondral bone, since it is a transition
portion presenting some characteristics of the cartilagi-
nous tissue, such as the deposition of collagen type X, and
some characteristics of the bone tissue, such as the pres-
ence of alkaline phosphatase and of mineral deposits. Its
function is to provide a good attachment between bone
and cartilage, and transfer the forces from the joint to the
subchondral bone (Oegema, 1997).
ARTICULAR CARTILAGE
The function of articular cartilage is to transfer and dis-
tribute the load forces to the subchondral bone; the dispo-
sition and localization of structural proteins such as
collagen and proteoglycans is optimized to perform this
function. Collagen type II, in particular, is the most abun-
dant component of the ECM in hyaline cartilaginous tissue.
Another abundant component of the ECM is the proteogly-
cans, responsible for the water uptake and osmolarity
maintenance. There are two classes of proteoglycans, large
aggregating proteoglycans such as aggrecan and smaller
ones, such as decorin, biglycan, and fibromodulin (Bhosale
and Richardson, 2008). Articular cartilage can be divided
into three main zones: moving from the articular surface
to the subchondral bone, the superficial, the transitional,
and the radial or deep zones. The superficial and transi-
tional zones each constitute 10% of the height of the artic-
ular cartilage layer. The radial zone represents instead the
bulk of articular cartilage, accounting for 80% of it (Hun-
ziker et al., 2002). Chondrocytes represent the 2% of the
component of the articular cartilage, and they are the only
cell type present in this tissue. Chondrocytes are charac-
terized by a round shape, different size and orientation
along the cartilage height, and are surrounded by two
main ECM proteins, namely collagen type II and aggrecan.
Chondrocytes are fairly small cells, presenting a diameter
of 13 mm, a surface area of 821 mm2, and a volume of
1,748 mm3, approximately. These features do not vary
much among the cartilage zones, with the exception of the
hypertrophic one (Hunziker et al., 2002). When a chondro-
cyte becomes hypertrophic, its volume increases up to 20
times (Farnum et al., 2002) and starts to produce collagen
type X. Chondrocytes are organized in chondrons which
FIGURE 1. Schematic representation of the
osteochondral tissue and its components and
osteochondral tissue from two histological sec-
tions. Modified from Buckwalter, 1994, Kwan
Tat , 2009, and https://www.tcd.ie/bioscien-
ces/gallery/.
BIRTH DEFECTS RESEARCH (PART C) 105:34–52 (2015) 37
are the primary structural, functional and metabolic unit
in hyaline cartilage. A chondron comprises the chondro-
cyte and the pericellular molecular environment of which
collagen type VI and IX are the major components. These
ECM proteins are present only in close proximity of the
cell, while they decrease to very low levels in the carti-
lage matrix. Beside an axial characterization of the
matrix, another distinction can be done, based on the
matrix between one chondron and the following one.
Close to the chondrocyte the pericellular matrix is rich in
collagen types VI and IX, as mentioned above, with the
addition of proteoglycans such as hyaluronan (Mason,
1981), sulfated proteoglycans (Poole et al., 1984), and
biglycans (Miosge et al., 1994) as well as matrix glyco-
proteins such as fibronectin (Glant et al., 1985), link pro-
tein (Poole, 1997), and laminin (Durr et al., 1996).
Moving away from the chondrocyte and its pericellular
matrix, the territorial zone is encountered, which is rich
in chondroitin sulfate. Further away, in the space
between chondrons, the inter-territorial matrix is local-
ized in which the main proteoglycans are rich in keratan
sulfate (Poole, 1997). In the superficial and transitional
zone, chondrons are exclusively single cells units,
whereas in the radial zone they contain on average 5–8
chondrocytes (Hunziker et al., 2002).
Moving from the radial to the transitional zone, the
ECM maintains the same composition and presents
decorin as proteoglycan, in addition to aggrecan. In this
region, collagen fibers pass from a vertical to a more hori-
zontal orientation. The surface zone of articular cartilage
is the one responsible for the lubrication of the joint. Its
ECM is mainly composed by collagen type I (Blitterswijk),
collagen type II, and lubricin or PRG4, a proteoglycan
present also in the synovial fluid responsible for joint
lubrication and synovial homeostasis (Musumeci et al.,
2014). The collagens are responsible for the strength and
the high shear stress resistance of the superficial layer
(Buckwalter et al., 1994). Here, collagen fiber orientation
progresses toward a completely horizontal configuration,
which contributes to the low friction mechanical proper-
ties of hyaline cartilage.
THE OC TISSUE AS A GRADIENT TISSUE
GRADIENTS IN OC DEVELOPMENT
During development, a rich orchestration of growth factors
act at different levels within the growth plate spatially and
temporally (Fig. 2). To ensure the proliferation of progeni-
tor cells on the superficial layer, but prevent it in the
lower part, a PTHrP gradient is formed. “Elder cells” move
downwards and keep dividing, as long as the PTHrP effect
is present. Once they reach the lower resting phase of the
growth plate, the effect is no longer present, and this
makes them proceed toward the next step of maturation.
Similarly, once the chondrocytes have reached the hyper-
trophic stage, BMP signaling plays a major role in bone
formation. The BMP effect is determined by a combination
of cell susceptibility and BMP antagonist. BMP-2 and -6
are produced by osteoblasts and hypertrophic chondro-
cytes. Their expression is higher in the hypertrophic zones,
and decreases while moving upward in the resting and
proliferative zones. Their effect also decreases from the
hypertrophic zone toward the proliferation and resting
zones, since the expression of their receptor BMPRIA fol-
lows the same trend (Nilsson et al., 2007). The activity of
BMPs is finely regulated, in order to stimulate the right
portion of the growth plate, and therefore an opposite gra-
dient of BMPs antagonists can be found. BMP-3 is consid-
ered an antagonist, since its action inhibits BMP
stimulated bone formation (Gamer et al., 2008). Among
the antagonists, noggin, gremlin, chordin, and BMP-3 are
more highly expressed in the resting zone compared to
the proliferative and hypertrophic ones (Nilsson et al.,
2007), thus resulting in an increased gradient of osteoin-
ductive signals within the growth plate. The development
of chondrocytes toward the hypertrophic state is finely
tuned via the expression of antagonists, such as Gremlin 1,
Frizzled-Related Protein, and Dkk-1. Their expression
presents a decreasing trend from the resting zone, in
which their presence is the highest toward the hyper-
trophic zone in which their levels are the lowest (Leijten
et al., 2012).
STRUCTURAL GRADIENT–FIBRILS AND ECM COMPOSITION
Due to its compartmental architecture, the OC tissue
presents a variety of axial gradients along its structure. In
the OC tissue, the structural gradient is defined by the
composition and organization of the ECM (Figs. 1 and 3).
As mentioned earlier, the subchondral bone is a mineral-
ized tissue comprised primarily of collagen type I and HA.
HA, the inorganic component of subchondral bone, com-
prises 85.8%6 3.4% of its dry weight, decreasing to
65.1%6 2.3% in the calcified cartilage to completely dis-
appear in the hyaline cartilage (Zhang et al., 2012). Colla-
gen type I is present in bone and starts to decrease in
content from the mineralized cartilage. In cartilage, colla-
gen type I can be found only in the surface layer. In the
mineralized cartilage lying above subchondral bone, the
FIGURE 2. Schematic representation of the growth plate and the gradients
formed by growth factors. The arrow direction describes a descendent gradi-
ent. Modified picture from http://serkadis.net/.
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residing cells are a particular type of chondrocytes named
hypertrophic chondrocyte, which present the peculiar
characteristic of producing collagen type X, and are
embedded in mineralized ECM. In this deep zone of the
OC tissue, the direction of the fibrils do not play a major
role, since the integrity and the shock absorption ability is
given by the mineralization of the ECM and the presence
of collagen type X. Collagen type II starts to appear in the
radial zone in thick fibers, with a direction that is perpen-
dicular to the articular surface. From the radial zone mov-
ing towards the superficial zone, mineralization also
disappears. In the transitional zones, collagen type II fibers
increase in number, but decrease in diameter and assume
a more parallel direction, to become totally parallel to the
articular surface in the superficial zone. This direction
determines the greatest tensile and shear strength (Bho-
sale and Richardson, 2008). Conversely, the amount of gly-
cosaminoglycans (GAGs) forms a gradient opposite to the
one generated by the collagen, decreasing from the radial
zone toward the joint surface. GAGs are responsible for
the gradient in stiffness within articular cartilage: as the
total proteoglycan concentration decreases, the compres-
sive stiffness also decreases (Mansour).
CELLULARITY GRADIENT AND PERICELLULAR ENVIRONMENT
A variety of cells are present in the OC tissue. As previously
described, the subchondral bone is comprised of osteoblasts
for collagen and mineral deposition, osteoclasts for bone
remodeling, and calcium mobilization, and osteocytes for
their regulation and mechanotransduction (Knothe Tate
et al., 2004). Being highly vascularized, bone contains endo-
thelial cells composing the vascular network, which is miss-
ing in articular cartilage, due to its typical avascular nature.
The variation from bone to cartilage tissue in terms of cells
does not follow a gradient. However, within the cartilage tis-
sue a gradient in cell distribution, size, and deposited peri-
cellular matrix can be observed. Within cartilage, the only
cell type present has been always believed to be chondro-
cytes. Although defined as chondrocytes throughout the tis-
sue, this simplification is misleading since profound
differences are present in the behavior, morphology, and
function of these cells among the cartilage zones. Chondro-
cytes vary in number, size, and disposition, depending in
which region they are located. The gradient in chondrocyte
density per zone can be summarized by a variation from
7,000 to 24,000 cells/mm3 (Fig. 3). Beside the variation in
cell number, chondrocyte appearance varies in a gradient
way. The cell body decreases in size from the hypertrophic
zone toward the superficial layer. In addition, the morpho-
logical and functional units of hyaline cartilage, the chon-
drons, display a gradient through the cartilage layers. In the
radial zone, chondrons are arranged in columns. Even if
chondrocytes have the characteristic of no direct cell-cell
connections, the tails of the chondrons are entangled, in
order to guarantee continuity from one chondron to the fol-
lowing one. The number of chondrocytes per chondron is
estimated to change from one to eight, with the lowest num-
ber in the superficial zone and the highest in the radial zone
(Hunziker, 2002; Hunziker et al., 2002). Moving toward the
articular surface, as the chondrocytes/chondron number
decreases to one, the overall number of chondrocytes
increases. Their appearance passes from column like struc-
tures to single entities dispersed in the ECM. An additional
switch in cell number, function, and morphology can be
seen from the transition to the superficial region of the
articular cartilage. The collagen produced by these cells
changes from collagen type II to collagen type I. Their mor-
phology change from rounded to flat and they form a super-
ficial cell layer with a very low amount of ECM separating
them from each other. Additionally, the superficial region is
the area with the highest proliferative rate (Blitterswijk
et al., 2002). From a developmental point of view, the matu-
ration of chondrocytes follows an opposite trend compared
to the cell density. Hayes et al. (2001) reported that the
development of chondrocytes follows an appositional direc-
tion. The cartilage progenitor cells are located in the super-
ficial region, and their development is shown to pass
through the cell phenotypes encountered from the
FIGURE 3. On the left side, schematic repre-
sentation of the osteochondral tissue. On the
right side, directions of its gradients. The stiff-
ness gradient continue in the subchondral
bone, whereas the nutrient gradient stops in
the radial zone. Modified from Woodfield,
2005.
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superficial to the deep region. Eventually, the chondrocyte
would enter in the hypertrophic stage, which is thought to
be the last stage of their development (Pacifici et al., 1990).
STIFFNESS GRADIENT
From the subchondral bone, the mineralization and stiff-
ness of the ECM decreases when moving toward the artic-
ular surface, as shown in Figure 3. This can be defined as
a discrete gradient, since the subchondral bone and the
mineralized cartilage present the highest amount of miner-
als that disappear completely in the other zones compos-
ing the articular cartilage. The subchondral bone has an
elastic modulus of 3.96 1.5 GPa, which decreases in the
mineralized cartilage to 0.326 0.25 GPa (Mente and Lewis,
1994). From the mineralized cartilage region moving
towards the articular surface, the stiffness decreases from
0.6 66 0.05 MPa in the deep zone to 0.246 0.05 MPa in
the superficial zone (Rolauffs et al., 2010). Articular carti-
lage has also the peculiarity to change its mechanical
properties when a loading is applied dynamically. Due to
its highly viscoelastic character, its dynamic stiffness
increases with increasing the loading frequency, spanning
from 4 to 10 MPa (Treppo et al., 2000; Moroni et al.,
2006). The final load is borne by the bone and the carti-
lage has the function to transfer the forces through the
ECM.
NUTRIENTS/O2 GRADIENT
The bone side of the OC tissue is reached by blood vessels
that are responsible for bone nutrient supply and waste
removal. One of the major anatomical characteristics of
cartilage, instead, is the absence of blood vessels through
the entire width. Nutrients are transported to the cells
mainly by diffusion from the synovial fluid. Nutrient trans-
port is also sometimes thought to be assisted by move-
ment of fluid in and out of cartilage in response to cyclic
loading of the tissue (O’Hara et al., 1990). Therefore, gra-
dients of nutrients and metabolic byproducts exist through
cartilage due to the balance between transport and rates
of cellular metabolism (Zhou et al., 2008). This process is
aided by the presence of proteoglycans that have the abil-
ity of retaining water, which flows in with the nutrients
during loading relaxation and flows out with the metabo-
lites during compression. Among the nutrients, glucose
represents the primary source of energy. Pyruvate, the
product of glycolysis, is converted in acetyl coenzyme A,
which is the main supplier of carbon in Krebs cycle. A glu-
cose gradient from the synovial fluid toward the deep
zone of cartilage is also present as shown by Zhou et al.
(2008). Glucose is not only the most important source for
energy production, but also a key component in GAG syn-
thesis. It has been shown that across cartilage from the
synovial side to the subchondral bone, a glucose gradient
exists (Prydz and Dalen, 2000; Fig. 3). Similar to glucose,
the oxygenation of cartilage comes from the synovial fluid.
Therefore, a gradient of oxygen is formed from the joint of
the surface toward the radial zone (Fig. 3). The oxygen
tension of synovial fluid in humans is 6.5–9.0% (50–
70 mm Hg; Falchuk et al., 1970; Lund-Olesen, 1970).
Measured oxygen tension in articular cartilage ranges
from 7% (53 mm Hg) in the superficial layer, to <1%
(7.6 mm Hg) in the deep zone (Silver, 1975; Fermor et al.,
2007) of the oxygen tension of synovial fluid.
Gradient Scaffolds for OC Regeneration
GENERAL REQUIREMENTS
In the past few years, the number of publications involving
scaffolds addressing the gradient nature of the OC tissue
has greatly increased. Studies involving structural porosity
gradient were proven to increase the cell seeding effi-
ciency of human osteosarcoma cell line SaOs-2 (Sobral
et al., 2011) and to mimic in vitro the gradient structure
of the cartilage in terms of chondrocytes and ECM distri-
bution (Woodfield et al., 2005). In the literature, it is pos-
sible to find several studies aiming at the treatment of
articular cartilage alone or at the development of biphasic
scaffolds for the treatment of bone and cartilage as sepa-
rate tissues. Due to the wide range of gradients present in
the OC tissue, several choices can be made in terms of gra-
dient scaffolds. Typically, biphasic or triphasic scaffolds
have been developed, displaying either discrete or continu-
ous gradients (Singh et al., 2010, Mohan et al., 2011,
2014; Elizaveta Kon, 2014). To define biphasic or triphasic
scaffolds, different materials can be chosen. In this respect,
the selection of biomaterials needs to take into account
not only their biocompatibility, but also the effect that
each material will play on the seeded cells (Tables 1 and
2). For the scaffold preparation, natural or synthetic poly-
mers can be used. A logical criteria for the selection of
natural polymer candidates passes through the compo-
nents of the ECM. For the bone compartment, collagen
type I combined with HA was used to produce scaffolds or
to cover the underlying polymer by coating the pore sur-
face (Aydin, 2011), to mask the synthetic polymer and
present an ECM like environment for cell attachment,
growth, and differentiation. For the regeneration of the
cartilage portion, collagen type II, glycosaminoglycans, and
hyaluronic acid have been used (Zhao et al., 2013). For
both bone and hyaline cartilage, the most common syn-
thetic polymers used are poly(lactic acid) (PLLA; Solchaga
et al., 2005), poly(glycolic acid) (PGA; Aydin, 2011), and
polycaprolactone (PCL; Ding et al., 2013).
Among other properties, an OC scaffold should be bio-
degradable with a degradation rate matching the rate of
ECM production, and should have high levels of porosity
and pore interconnectivity for cell attachment, and gas,
nutrient, and waste products exchange, (Aydin, 2011). The
mechanical properties of the fabricated scaffolds should
match the gradient in mechanical properties present in the
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OC tissue, with a stiffer scaffold for the bone compartment
and a gradually softer scaffold for the cartilage compart-
ment. Additionally, the inner geometry of the construct
must be taken into consideration, ideally mimicking the
structural and architectural properties of the native tissue.
CHOOSING CELLS
After considering general design criteria in fabricating a
scaffold for OC regeneration, one should consider whether
the scaffold will be directly implanted or seeded with cells
before implantation. In the latter case, two main solution
have been proposed: (i) the direct use of already differen-
tiated cells (Cao et al., 2003; Martin et al., 2007; Jeon
et al., 2014) or (ii) the use of progenitor cells, namely
MSCs from different sources (Heymer et al., 2009; Grayson
et al., 2010). When differentiated cells are used, the part
of the scaffold, which will be in contact with the subchon-
dral bone is loaded with osteoblasts; to allow vasculariza-
tion, this portion of the scaffolds must provide the space
for vessel ingrowth. Therefore, an interconnected pore net-
work is required. For the portion of the scaffold aimed to
regenerate hyaline cartilage, the use of chondrocytes is a
natural choice. As cartilage is not vascularized, the struc-
ture of the scaffold does not need as large pores as the
ones in the bone side. The use of already differentiated
cells presents some limitations, since cells must be har-
vested, expanded in laboratory, seeded in the construct,
and finally implanted. Another possibility is the seeding of
progenitor cells (Blitterswijk). Since both chondrocytes
and osteoblast originates from the bone marrow, the use
of bone marrow derived MSCs has attracted significant
interest for tissue engineering applications, either when
these cells are used alone or in combination with scaffolds
(Sundelacruz and Kaplan, 2009; Panseri et al., 2012;
Anderson et al., 2014). When MSCs are used, the concept
of scaffold design changes, since it must present the right
cues to direct their differentiation toward the osteogenic
and chondrogenic lineage in the proper compartment of
the construct. Several studies have aimed at generating
scaffolds able to drive MSCs differentiation toward the tar-
geted lineage. Among them, the use of growth factors in
soluble form or bound to the scaffold structure are the
ones presenting the strongest effects (Singh et al., 2008;
Grayson et al., 2010; Budiraharjo et al., 2013). Recent
studies demonstrated that MSCs respond to stimuli coming
from the matrix stiffness as well (Even-Ram et al., 2006;
Tse and Engler, 2011). Cells attaching to a soft material
are more prone to differentiate toward the chondrogenic
TABLE 1. Summary of the Biphasic Scaffolds Described, Indicating the Biomaterials, Cells, and Growth Factors used and the Main Results for Each Construct
Author In vitro/in vivo Material subchondral bone 1 cells Material cartilage 1 cells Main findings
Schaefer et al., 2000 In vitro PGA nonwoven meshes; chondrocytes PLGA/PEG foams, Periosteal
cells
Increased ECM mineralization, GAG
synthesis, integration with subchon-
dral bone
Schek et al., 2004 In vivo, nude mice HA ceramic Fibroblasts expressing
BMP-7
PLLA sponge Chondrocytes Bone and blood vessel, mineralized
transition tissue, Cartilaginous
tissue
Cao et al., 2003 In vitro Plotted PCL Stromal cells from iliac
crest
Plotted PCL Rib cartilage
chondrocytes
Bone like tissue formation Cartilage-like
ECM
Ding et al., 2013 In vivo, nude mice Plotted PCL 1 HA 1 MSC PGA/PLA nonwoven
fibers 1 chondrocytes
Osteogenic and chondrogenic
markers, interface with hyper-
trophic cartilage
Kandel et al., 2006 In vivo, sheep CPP Chondrocyte layer OC regeneration, some sign of carti-
lage maturation
Duan et al. (in press) In vivo, rabbit Salt leached PLGA 300-450 mm 1 MSC Salt leached PLGA 100-200
mm 1 MSC
Simultaneous regeneration of articular
cartilage and subchondral bone
Chen et al., 2012 In vivo, rabbit BMP-2-activated HA/chitosan-gelatin TGF-b1-activated chitosan-
gelatin
Regeneration of articular cartilage and
subchondral bone
Re’em et al., 2012 In vivo, rabbit alginate-sulfate, alginate, 0.18%D-glu-
conic
acid/hemicalcium salt 1 BMP4
alginate-sulfate, alginate,
0.18%D-gluconic
acid/hemicalcium salt 1 TGF-
b1
ECM composition of hyaline cartilage
with no signs of mineralization, new
formed woven bone in the bottom
part
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lineage, whereas cells on a stiffer material will be driven
toward the osteogenic lineage. Yet, the use of MSCs in the
context of classical tissue engineering, where cells are
expended and then seeded in vitro to allow for tissue for-
mation before constructs can be implanted, presents some
limitation, such as the time of culture and the need of
external factors for their differentiation in vitro. A further
approach to overcome this problem may consist of the
development of in vitro systems that drive the differentia-
tion of MSCs in a regional way, depending on the part of
the OC tissue that they will be in contact with. Once such
a system is developed and validated with in vitro and in
vivo studies, one could consider to directly implant this
scaffold and exploit the intrinsic presence of MSCs in the
implantation site. When combined with surgical techni-
ques like microfracture, where small holes are drilled to
reach the bone marrow present in the subchondral bone
compartment, the bone marrow will flow in the scaffold
from the underlying bone providing the MSCs that will col-
onize the scaffold and differentiate toward the right line-
age, depending on the cues provided by the construct.
BIPHASIC CONSTRUCTS
In its most simplistic version, the OC tissue can be seen as
a biphasic tissue being composed by a bone phase and a
cartilaginous phase. In most studies, biphasic scaffolds are
not only based on the different materials or structures of
the two components, but also on the different cells cul-
tured in the resulting scaffolds. In 2000, the work of
Schaefer et al. presented an in vitro engineered scaffold
based on PGA nonwoven meshes seeded with primary
bovine chondrocytes and PLGA/PEG foams seeded with
expanded periosteal cells. The two constructs showed
promising results in vitro, due to an increase in GAG pro-
duction in the cartilage side, an increase in mineralization
of the ECM in the bone side, and a good integration of the
two phases after 4 weeks of culture (Schaefer! et al.,
2000). Similarly, in the work of Schek et al. (2004) the
constructs presented a biphasic design in material, cell
types, and growth factors. The scaffold consisted of the
combination of HA-based ceramic on the bone side and a
PLLA sponge on the cartilage side. The two parts were
seeded with fibroblasts expressing BMP-7 on the ceramic
side and chondrocytes within the sponge. The implanta-
tion of these constructs in nude mice determined the gen-
eration of a biphasic tissue with all the structures present
in the OC interface, bone and blood vessel in the ceramic
part, a mineralized transition tissue, and a cartilaginous
tissue on the polymeric side.
These examples showed initial promising results in
achieving OC tissue regeneration. Yet, the scaffold structures
developed in these studies are still characterized by a tortu-
ous and not completely interconnected pore network, thus
limiting their potential translation to larger defects, where
nutrient diffusion and waste removal become more critical
for the viability and functionality of the regenerated tissue.
For these reasons, additive manufacturing technologies
gathered a great interest and momentum in the past two
decades, due to their versatility in tuning scaffold features
such as fiber spacing, fiber diameter and fiber deposition
pattern. This allows one to obtain fully interconnected 3D
structures with customizable pore network, resulting in a
high flexibility in tuning physicochemical, structural, and
mechanical properties of the fabricated scaffolds. Cao et al.
(2003) studied the coculture of iliac crest stromal cells and
chondrocyte in a biphasic PCL construct. The scaffold was
plotted and then partitioned vertically into two halves with
a gap between them, leaving only a small portion in contact
with each other. The first half was seeded with iliac crest
stromal cells and cultured for 18 days under osteogenic
conditions, and the other half was seeded with rib cartilage
chondrocytes. The resulting coculture construct was cul-
tured in vitro for 8 weeks in a coculture medium. The two
compartments were kept together by the addition of fibrin
glue to both cell suspensions prior to seeding. Even though
the in vitro results were satisfactory, additional analysis
before further use of this scaffold in vivo should be per-
formed, as also suggested by the authors. More recently,
Ding et al. (2013) tested a biphasic scaffold to regenerate a
goat femoral head. This in vivo study was carried out in
nude mice, and the results were analyzed by using goat
proximal femoral condyles as positive controls and
implanted cell-free scaffolds as negative controls. The scaf-
fold had a femoral condyle shape and consisted of a lower
part made of a blend of PCL and HA plotted via fused depo-
sition modeling, on top of which a nonwoven fiber scaffolds
of PGA/PLA was located to regenerate the articular cartilage
tissue of the femoral head. The two components of the scaf-
folds were seeded with goat hMSCs in the bone compart-
ment and chondrocytes in the cartilage compartment,
respectively. The cell seeded constructs were combined
after 2–3 weeks of culture under osteogenic medium for the
lower part and chondrogenic medium for the top part. The
combined scaffolds were implanted and analyzed after 10
weeks, showing expression of osteogenic and chondrogenic
markers in the two components, whereas the negative con-
trols presented only sparse fibrotic tissue. Furthermore, this
system generated an interface zone, in which hypertrophic
cartilage with immature calcified tissue could be observed,
thus approaching the structural and biophysical properties
of the native tissue.
To test scaffolds for OC regeneration in vivo the use of
mice or rats is limiting, allowing only subcutaneous
implantations. Larger animal models, such as rabbits, pigs,
or goats, are necessary to fully validate new scaffolds in
an orthotopic implantation model. Kandel et al. (2006)
produced a porous calcium polyphosphate (CPP) scaffold
seeded with autologous chondrocytes and implanted the
construct in a sheep OC defect. The scaffolds supported
OC regeneration with shown indications of cartilage
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maturation, bone ingrowth, and fusion, proceeding from 4
to 9 months of implantation. Yet, some fibrotic tissue was
also observed at the bone interface, thus indicating a sub-
optimal integration of the construct. Duan et al. (2013)
tested biphasic scaffolds with different pore sizes in com-
bination with and without MSCs in a rabbit model for OC
regeneration. The scaffolds were prepared by PLGA salt
leaching technique and presented a top part for the chon-
dral regeneration with height of 1 mm and an osseous
layer of 4 mm. The constructs were implanted for 12
weeks. The scaffolds without cells displayed better results
than the untreated defects, although the defects implanted
with cell-free scaffolds showed inferior repair in the chon-
dral layer. Among the 5 pore sizes combinations tested,
the construct with the best histological and biochemical
scores had pore size of 100–200 mm for the chondral side,
and 300–450 for the osseous part in combination with
cells.
The use of already differentiated autologous cells has
some limitations in terms of source and harvesting proce-
dures. Thus, to overcome these drawbacks and to mimic
what happens in the healing process of bone and cartilage,
research efforts moved to the use of MSCs. To direct their
differentiation toward the chondrogenic and the osteo-
genic lineage, the design of scaffolds geared to further
functionalization to present growth factors in the right
construct location in space and time. The combination of
MSC seeded scaffolds and delivery of biological signals
was studied in vivo by Chen et al. (2011). The constructs
consisted of a plasmid TGF-b1-activated chitosan-gelatin
scaffold for the chondrogenic layer and a plasmid BMP-2-
activated HA/chitosan-gelatin scaffold for the osteogenic
layer. The structures were separately seeded with human
MSCs and cultured for 1 week. Prior to implantation, the
separated constructs were fused with fibrin glue and cul-
tured for another week in vitro. The constructs promoted
the growth and differentiation of MSCs and supported the
regeneration of articular cartilage and subchondral bone
in a rabbit knee defect after 12 weeks of implantation.
The same outcome was reached one year later by Re’em
et al. (2012), with a cell-free scaffold based on 0.1%
alginate-sulfate (w/v), 1% alginate (w/v), and 0.18% (w/
v) D-gluconic acid/hemicalcium salt loaded with TGF-b1
and BMP-4 prepared in situ. After 4 weeks of implantation
in rabbits, the top layer was integrated with the surround-
ing cartilage and displayed the typical ECM composition of
hyaline cartilage with no signs of mineralization. The bot-
tom part presented newly formed woven bone.
The use of biphasic scaffolds has shown some degree
of success, therefore highlighting that the strategy to
mimic, as closely as possible the native OC tissue is a
promising route for functional regeneration. However,
when strictly looking at biomimicry principles, biphasic
scaffolds are not satisfactory, since they treat bone and
cartilage as two distinct compartments, whereas the two
tissues are intimately interconnected, as previously
explained. Additionally, in most of the above presented
studies the presence of only two parts implicitly neglected
the presence of the transition zone of calcified cartilage.
Furthermore, biphasic scaffolds do not display all the gra-
dients that characterize the OC tissue and the further divi-
sion of cartilage into its specific zones.
TRIPHASIC AND MULTILAYERED SCAFFOLDS
In an effort to mimic more closely the native OC tissue, tri-
phasic, or multilayered scaffolds have been developed by
several groups. Two studies presented an intriguing scaf-
fold design but their biological relevance was not studied
in vitro nor in vivo (Harley et al., 2010; Aydin, 2011). In
the first case, a gradient in mechanical properties was gen-
erated. In the second study, only natural materials from
the OC ECM were used and an interface similar in ECM
properties to the natural OC tissue interface was gener-
ated via the phenomena of interdiffusion of the two mate-
rial phases followed by freeze drying. The bone side of the
triphasic scaffolds is the most consistent since the major
part of the studies found in literature presented a compos-
ite of PLGA or PLA combined with tricalcium phosphate,
bioglasses or HA. However, the cartilaginous portion varied
in composition, material used, and production method. In
2002, Sherwood et al. (2002) presented multiphasic scaf-
folds. Each phase consisted of a different porosity, material
composition and stiffness. The cartilage compartment was
made with D,L-PLGA (50:50)/L-PLA with 90% porosity
obtained by salt leaching. The bone compartment was a
composite made with L-PLGA (85:15)/tricalcium phos-
phate with a porosity of 55%. To prevent delamination,
the intermediate area presented an increase in porosity
(from 65 to 85%) as well as in lactic acid content (from
PLGA 85:15 to PLGA 50:50 PLA), when moving from the
bone to the cartilage compartment. The mechanical testing
proved that the composite had a tensile strength similar to
cancellous bone. Chondrocytes were seeded, preferably
attached to the cartilage scaffold compartment, and after 6
weeks of culture in vitro formed cartilage like tissue. By
solving the problem of delamination, however, the resem-
blance of the construct to OC tissue was compromised. A
better result in terms of tissue stratification within the
construct was obtained by Jiang et al. (2010). In this study,
the variation in phases was generated by different combi-
nations of materials and cells. Similarly, to the work of
Sherwood, the bone compartment was based on PLGA
microspheres with a mineral part consisting of bioglass
seeded with osteoblasts. Chondrocytes embedded in an
agarose hydrogel formed the cartilage compartment. The
intermediate phase was similar to the cartilage one, with
the addition of PLGA and bioglass ceramic microspheres,
in order to stimulate the formation of mineralized carti-
lage. In each region, cells formed the proper tissue. Even if
in the intermediate zone no markers of hypertrophic
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cartilage were analyzed, chondrocyte within a mineralized
matrix were observed. The stratification of tissues within
the construct was satisfactory. However, hydrogels lack
sufficient mechanical properties, which are in the order of
magnitude of 10–100 kPa, whereas cartilage and subchon-
dral bone mechanical properties are in the order of 0.45–
0.8 MPa (Mansour) and 2.36 1.5 GPa (Mente and Lewis,
1994), respectively. Beside the similarities in the bone
compartment, Heymer et al. (2009) used a different
approach for the design of the chondral side. A porous
layer of 3 mm of bovine collagen type I and hyaluronan
comprised the cartilage portion, while the bone side was
based on PLA composite with a mineral phase of HA and
b-tricalcium phosphate. In between the two layers, a
hydrophobic region resulted from joining the two struc-
tures. The study focused on cartilage regeneration only.
Human MSCs were suspended in a collagen type I gel and
seeded on the upper layer. After 3 weeks of culture under
chondrogenic conditions, chondrocyte-like cells were visi-
ble in the upper third of the top layer and were sur-
rounded by collagen type II and proteoglycans. At a
molecular level, cells expressed specific marker genes such
as COMP, aggrecan, and collagen types II and X. Despite
promising results for cartilage regeneration, the lack of
bone regeneration results in only a partial validation of
such a scaffold design. Recently, Levingston et al. (2014)
developed a system to generate gradients in material com-
position, stiffness, and porosity via an “iterative layering”
freeze-drying technique, based on the consequent apposi-
tion of layers on top of each other followed by freeze-
drying. This design differed from the previous one as the
scaffold composition was based only on natural polymers
commonly found in the OC ECM. The bone layer was com-
prised of a commercial form of collagen type I and HA.
The intermediate layer consisted of a mixture of collagen
types I and II, and HA. Similarly, the cartilaginous layer
was based on collagen types I and II, HA, and sodium
salts. The scaffolds were seeded with MC-3T3 pre-osteo-
blasts, which proliferated and populated all the compart-
ments over a period of 14 days confirming the
biocompatibility of the construct. Such constructs may be
promising for OC applications, although an in vitro study
with human cells and validation in preclinical animal mod-
els are needed to further confirm these preliminary
results.
Three-layered constructs were also tested in vivo in
large animal models. In 2010, Marquass et al. (2010) com-
pared OC autografts with scaffolds presenting a collagen
type I hydrogel on the chondral side, an intermediate acti-
vated plasma gel phase and a tricalcium phosphate osse-
ous phase. The constructs were seeded with pre-
differentiated autologous MSCs toward the chondrogenic
lineage and implanted for 6 and 12 months in an OC
defect in sheep knee. No major differences in terms of his-
tological scores were displayed by the groups. At 12
months, biomechanical and macroscopic analysis did not
show any difference. Autologous MSC-seeded triphasic
implants showed comparable repair quality to OC auto-
grafts in terms of histology and biomechanical testing.
More recently, multilayered scaffolds based on synthetic
polymers, such as PCL and polyurethane, with and without
the addition of natural ECM components, were evaluated
in vivo by Liu et al. (2014) and by Dresing et al. (2014).
In both studies, MSCs were seeded and the scaffolds
implanted in a rabbit model for 12 weeks. Starting from
an electrospun PCL mesh as periosteal scaffold, Liu et al.
freeze-dried it first with a collagen type I and hyaluronan
solution, in order to generate the cartilage portion, and
then with tricalcium phosphate for the osseous phase. The
electrospun mesh promoted the alignment of seeded bone
marrow derived MSCs seeded in a fashion resembling the
superficial zone of hyaline cartilage. The cell-seeded tri-
phasic construct led to an improved regeneration of an OC
defect in a rabbit model matching the histological scores
of autografts (Liu et al., 2014). The fully synthetic con-
struct used by Dresing et al.(2014) was based on poly(es-
ter-urethane) (PUR) in different structures for the
regeneration of cartilage, subchondral bone, and cortical
bone. The cartilage compartment was made by salt
leached PUR, the subchondral bone compartment by elec-
trospun PUR, and the bone compartment by a salt leached
combination of PUR and nano HA. The bone and cartilage
side presented a similar porosity, 85% and 87%, respec-
tively. The major differences were found in terms of aver-
age pore size 121 and 251 mm, respectively, and of the
addition of the mineral phase, resulting in a stiffness of
0.98 N/mm for the PUR scaffold alone and of 2.18 N/mm
for the composite PUR. Despite the elastomeric PUR was
easily press fitted in the OC defect, it did not provide any
advantage for tissue healing after 12 weeks. Furthermore,
this construct could not be really considered as a gradient
structure, since the intermediate phase could not be com-
pared with the other two. Additionally, this marked differ-
ence between the subchondral bone and the calcified
cartilage does not resemble the anatomical transition, in
which the two compartment are highly interdigitated (Fer-
guson et al., 2003). More recently, Jeon et al. (2014) devel-
oped a system to study OC development ectopically in a
nude rat. The desired scaffold to be tested was fitted into
a cylindrical shaped bovine OC plugs, and then implanted
subcutaneously in rats. This novel system may allow a
higher throughput screening of several OC constructs at
the same time than conventional subcutaneous implanta-
tion, accounting for the possibility to test up to 8 con-
structs per animal, thus reducing the number of animals
used and associated costs In this study, a multiphasic scaf-
fold was tested, based on bilayered 2% alginate containing
superficial chondrocyte on the upper part and middle-
deep chondrocyte in the lower zone for the cartilage com-
partment, which was joined with a PCL fused deposition
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modeling scaffold on top of an electrospun PCL layer, both
seeded with osteoblasts, for the bone and interface com-
partments. Immediately before implantation, the bone
compartment was also loaded with rh-BMP7. After 12
weeks, the scaffolds were analyzed. The use of bilayered
cartilage gel, however, did not recapitulate the compart-
mental structure of the native cartilage, nor zone specific
GAG distribution. Likewise, the bone compartment lacked
bone ingrowth and mineralization, probably due to insuffi-
cient vascularization. Despite the negative results obtained,
this study presented an elegant and new method for
screening several OC constructs. The division of the scaf-
fold in several zones aimed at resembling the gradient
behavior of the OC interface. Yet, one of the main possible
limitations in this study was the size of the construct, a
7 mm long scaffold, which might have encountered some
difficulties in integrating with the surrounding tissue,
likely due to the lack of associated vasculature.
CONTINUOUS GRADIENT SCAFFOLDS
In several studies, the Detamore’s group proposed and
tested an effective method to overcome the limitation
encountered in the production of discrete gradient scaf-
folds (Singh et al., 2008, 2010; Dormer et al., 2010, 2011;
Mohan et al., 2011, 2014). The first step consisted of the
generation of poly(D,L-lactide-co-glycolide) (PLGA) micro-
spheres, in which a desired compound can be added
(Singh et al., 2008). The loaded microspheres were dis-
persed in distilled water/PVA solution and placed in two
syringes each connected to a pump to control the flow.
The suspension was then pumped into a cylindrical mold
by varying the flow, in order to generate an opposite gra-
dient. The water/PVA was pumped out and the particles
were soaked in ethanol to facilitate physical attachment
among adjacent microspheres. An additional freeze-drying
step was then performed. The microspheres were loaded
with CaCO3 and TiO2 (Singh et al., 2010), TGF-b1 and
BMP-2 (Dormer et al., 2010), and chondroitin-sulfate and
bioglass (Mohan et al., 2014). If a single gradient was
desired, one pump was loaded with pure PLGA micro-
spheres. The biocompatibility of the system was tested on
porcine chondrocytes (Singh et al., 2008) and human
umbilical cord MSCs (Singh et al., 2010). When the micro-
spheres were loaded with bioactive signals, cells seeded
on gradient scaffolds outperformed the controls after 6
weeks of culture in terms of cell number, protein content,
and gene expression of osteogenic and chondrogenic
markers (Dormer et al., 2010). After these promising
results in vitro, scaffolds based on microspheres loaded
with BMP-2 on the bone side and TGF-b1 on the cartilage
side were implanted in a small mandibular condyle rabbit
model (Dormer et al., 2011). The profile for gradient con-
structs was linear, such that the transition region from
TGF-b1 to BMP-2 comprised the second quarter of the
scaffold volume, while the top quarter and bottom half
contained all TGF-b1 or BMP-2-loaded microspheres,
respectively. After 6 weeks of implantation, histological
and MRI analysis proved the addition of bioactive signals
to be less effective than expected. On the cartilage side,
the mechanical support of the scaffold played a more pre-
dominant role than the presence of TGF-b1 in generating a
smoother and thicker cartilage layer, when compared with
the nontreated defect. BMP-2 led to thicker trabeculae, but
also on this side, the mechanical support of the scaffold
played a greater role, since the subchondral bone layer
was more uniform in the gradient and blank scaffolds
compared with the nontreated ones. The total bone appo-
sition was not greatly influenced either, probably due to
the small size of the defect. An evolution of this system
was presented in 2013. The PLGA microspheres were
loaded with bioactive signals in combination with compo-
nents of the ECM. The region of the scaffold designed for
osteogenic differentiation presented microspheres loaded
with BMP-2 and bioglass, decreasing in number toward
the other side of the scaffold, rich in microspheres loaded
with TGF-b3 and chondroitin sulfate. MSCs displayed a
higher deposition of ECM markers when seeded on scaf-
folds loaded with the raw material, in comparison to scaf-
folds presenting the growth factors alone. Cells seeded in
scaffolds containing opposing gradients of CS/TGF-b3 and
BG/BMP-2 produced clear regional variations in the secre-
tion of tissue-specific ECM. Overall, this microsphere-based
scaffold proved to be an effective way to incorporate dif-
ferent biological signals of various natures in a scaffold
and generate opposite gradients of more than one com-
pound, thus closing the gap, to mimic the gradient behav-
ior of the OC tissue.
Most of the relevant studies connected to the use of
gradient scaffolds for the treatment of OC defects have
involved the use of scaffolds presenting discrete gradients
only. Although the OC interface presents discrete varia-
tions when moving from the subchondral bone to the car-
tilaginous compartment, a continuous gradient is present
within hyaline cartilage. A combinatorial approach of the
multilayered technique and the solution proposed by Deta-
more’s group can find, therefore, a possible application in
the development of a scaffold resembling even more the
characteristics of the OC interface.
THE GRADIENT IN THE CLINICS
Currently, only three gradient scaffold designs reached the
phase of clinical trials (Fig. 4). Two of them are biphasic
scaffolds and the last one is a triphasic scaffold design.
TruFiTM (Smith and Nephew, Andover, MA) is a biphasic
scaffold based on PLGA-PGA 75:25 and calcium phosphate,
which are glued together with a small amount of solvent
after preparation. The cartilage phase was prepared by the
addition of 10% poly(glycolide), reinforcing fibers to a
blend of PLGA-PGA 75:25 to improve the compressive
modulus (Slivka et al., 2001). The addition of the bone
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compartment and the effectiveness of the construct in
treating an OC defect was assessed in a goat orthotopic
model (Niederauer et al., 2000). The 2.7 mm high calcium
sulfate cylinder was glued with the previously prepared
1.2 mm high cartilage cylinder, and the glue provided a
thin film of 1 mm in thickness at the articulating surface
of the implant. Improved healing of the orthotopic defect
was shown after 16 weeks from implantation, with abun-
dant hyaline cartilage formation, integration, and good
bony restoration. The addition of chondrocyte to the
implant was also tested, but did not show any additional
beneficial effect. Two clinical studies conducted by Bedi
et al. (2010) and Barber and Dockery (2011) showed con-
troversial results. The first study described a slow
improvement of the injured site. The second clinical study
performed a CT scan on 9 patients with intervals between
2 and 63 months, showing no evidence of bone ingrowth,
osteoconductivity, or ossification. The decrease in implant
density over time reached levels of fibrous scar. Another
study from Quarch et al. (2014) showed no clinical
improvement in the 21 patients treated with this scaffold
design. After these results, the scaffold was used only to
treat cartilage defects. Positive results were obtained by
Carmont et al. (2009) on a 18 year old patient with a
large chondral defect. The patient returned to sport activ-
ities, indicating resolution of pain. Despite these controver-
sial findings, a number of clinical trials were conducted
(Dhollander et al., 2012; Joshi et al., 2012; Bekkers et al.,
2013; Hindle et al., 2014). In the study of Bekkers et al.
(2013), the scaffolds presented newly formed cartilage-
like tissue within the implant, which did not damage the
opposing and surrounding tissue after 12 months. Other
clinical studies showed in the best case modest improve-
ment (Dhollander et al., 2012), but a 70% failure in active
patients in the worst cases (Joshi et al., 2012). From these
studies, a general slow healing process with controversial
end results provided by the TruFitTM plug have been
observed, thus justifying for the continuous research for
more functional scaffold designs.
Another biphasic scaffold, which reached the clinical prac-
tice, was developed by Kon et al. (2009). The design was
based on calcium carbonate in the form of crystalline arago-
nite for the bone side and on hyaluronic acid for the cartilage
compartment (Kon et al., 2014a,2014b,2014c,2014d). The
first study performed in a goat model aimed at defining the
best construct design. The impregnation with hyaluronic acids
and the presence of drilled channels were tested. A defect of
6 mm in diameter and 8 mm deep was made in the medial
femoral condyle and the scaffolds were implanted for 6
months. Scaffolds presenting two drilled phases outscored the
other groups by displaying a smooth contour and newly
formed hyaline cartilage, well integrated with the surrounding
native cartilage, and with subchondral bone, respectively. This
construct hits the clinic in a first-in-man experiment. It was
used in a 47 years old nonprofessional sportsman, resulting
in successful treatment of a post traumatic femoral condyle
lesion of 2 cm2. After 18 months, the man returned to his
preinjury sport activity. MRI analysis at 24 months follow-up
showed promising results in terms of restoration of the artic-
ular cartilage (Kon et al., 2014a,2014b,2014c,2014d).
Among the multilayered scaffolds for OC regeneration,
a biomimetic construct consisted of different compositions
for each zone was also developed by Kon et al. (2009).
The cartilage compartment was based on pure collagen
type I, a tidemark-like structure was obtained by combin-
ing collagen type I and HA in a 60:40 weight ratio, and a
mineralized portion corresponding to the subchondral
bone presented a 30:70 weight ratio composition of colla-
gen type I and HA (Fin-Ceramica, Faenza, Italy). The three
components were synthesized separately and combined
together on top of a Mylar sheet, freeze dried, and gamma
sterilized. The intermediate and lower layers were formed
by nucleating bone-like nanostructured nonstoichiometric
HA into self-assembling collagen fiber, reproducing what
happens at the biological level in the neo-ossification pro-
cess. The resulting construct presented a gradient in min-
eral content from the bone to the chondral side and a
gradient in collagen content in the opposite direction. The
first study was performed in a horse animal model, testing
the efficacy of bilayered and trilayered scaffolds for the
regeneration of chondral and OC lesions (Kon et al.,
2010a, 2010b). The trilayered scaffolds were produced as
mentioned above, whereas the bilayered scaffolds were
missing the lower part, since they were intended for the
regeneration of a chondral damage. After 6 weeks of
implantation, both the chondral and OC lesions were filled.
The newly formed trabecular bone was visible at the sub-
chondral level and a tide mark-like region was present.
Unfortunately, fibrocartilage and not hyaline cartilage filled
the chondral compartment and a first alignment of the col-
lagen fibers was observed. In a subsequent study, the
addition of autologous chondrocytes seeded within the tri-
layered scaffold was studied in a sheep orthotopic model
to assess any additional beneficial effect of cells (Kon
et al., 2009). After a 6 months implantation, the presence
of newly formed cartilage in contact with the surrounding
tissue was observed in the constructs with and without
FIGURE 4. Pictures of the scaffolds which reached the clinical trials, a) Arago-
nite-based osteochondral scaffold (Agili-CTM, CartiHeal (2009) Ltd, Israel), b)
polimeric PLGA-PGA and Calciun sulfate bi-layer scaffold (Trufit CBTM, Smith
& Nephew, USA) and c) HA-Collagene type I three-layer scaffold (Maiore-
genTM, Finceramica, Italy). Modified from Elizaveta Kon, 2014.
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cells. In the lower compartment, newly formed subchon-
dral bone was observed. The presence within the subchon-
dral compartment of collagen type II and cells with
hypertrophic chondrocyte morphology suggested that the
scaffold-mediated regeneration of subchondral bone fol-
lowed an endochondral ossification process.
The use of the previously described biomimetic graded
scaffolds were applied in a clinical study for the repair of
knee chondral or OC lesion. An early analysis on its stabil-
ity was carried out in a pilot clinical trial. The first study
confirmed the attachment of the graft and only a partial
detachment in 2 patients out of 15. Visual scoring of the
repaired tissue revealed a normal repair score in one case
and a near-normal repair score in the other cases. Sub-
chondral bone formation without the presence of biomate-
rial was showed by histological analysis, thus indicating
the possible complete resorption of the biomaterial after 6
months. The cartilage tissue appeared not only repaired
but engaged in an ongoing maturation process (Kon et al.,
2010a,2010b). These encouraging results led to a longer
follow-up with randomized studies. A cluster of 27
patients were followed for 2 and 5 years after surgery for
knee chondral or OC lesions (size 1.5–6 cm2; Kon et al.,
2014a,2014b,2014c,2014d). Results showed a significant
increase of the quality of the regenerated tissue following
the International Knee Documentation Committee subjec-
tive score. The individual’s activity level, measured by
Tenger scores, depicted an increase from the preoperatory
to the 2 and 5 years follow-up. The Tenger scores
remained lower than the one before the injury, but did not
reach a statistically significant difference. After 2 years the
cartilage resulted completely filled in 65.2% of the treated
cases, the construct was completely integrated in 69.6% of
the cases, intact repair tissue surface was observed in
56.5% of the cases, and a homogeneous structure of the
repair tissue in 34.8% of the patients. However, the sub-
chondral lamina and bone resulted intact in only 7 and
47% of the cases, respectively (Kon et al., 2011). At 5
years follow-up, MRI evaluation revealed a significant
improvement in both cartilage and subchondral bone
status.
CONCLUSIONS
In this review, the gradients governing the regeneration of
the OC interface were presented alongside an overview of
the solution from the laboratory bench to the bed side.
The OC tissue is based on gradients from the early devel-
opmental stage until the fully developed body in the adult
organism. Nowadays, a lot of effort is made to design scaf-
folds that lead to the healing of the OC interface, attempt-
ing to re-establish the gradient present in the patient. We
have presented a few promising methods for the regenera-
tion of the OC tissue. To overcome the abnormalities that
still persist after midterm follow-up in clinical trials so far
available, a colloaboration between material scientists,
clinicians, and developmental biologists should be sought,
to elucidate those mechanisms and pathways involved in
the early stage of bone and cartilage development, and
include those signals into structures able to trigger not
only healing of the tissue, but also a proper regeneration.
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